Search results
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 3 days agoThe CDC advises that everyone ages 5 and older should get one dose of one of the current COVID ...
Two shots in one? Moderna's COVID-19 and flu vaccine reports favorable results
USA Today· 6 days agoModerna said Monday that its combination vaccine against flu and COVID-19 drew a greater immune...
FDA advises Covid vaccine makers to target new contagious strain for fall shots
NBC Universal via AOL· 3 days agoThe FDA advised drugmakers to update Covid vaccines to target the KP.2 strain, a descendant of the...
Novavax seeks FDA nod for updated COVID-19 vaccine By Investing.com
Investing.com· 2 days agoFood and Drug Administration (FDA) for its updated JN.1 COVID-19 vaccine, NVX-CoV2705, for...
Moderna’s New Flu-COVID Combi mRNA Vaccine Outperforms Separate Shots In Trials
IFLScience· 5 days agoModerna became a household name thanks to the success of its mRNA vaccine against COVID-19. Along...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News via Yahoo News· 1 day agoThe U.S. Food and Drug Administration (FDA) has recommended thatCOVID vaccine manufacturers update...
FDA asks COVID vaccine makers to target KP.2 strain with updated shots
Reuters· 2 days agoThe U.S. Food and Drug Administration recommended COVID-19 vaccine makers target the KP.2 strain...
FDA recommends COVID jab manufacturers update formulas to combat new strain
BizPac Review· 1 day agoThe U.S...Administration (FDA) announced Thursday that manufacturers of the COVID vaccines should focus on the KP.2 strain of the JN.1 variant. “Based..
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA Today· 3 days agoCases of the latest COVID-19 variant, also known as KP.3, are on the rise in the United States....
Moderna (MRNA) Submits Updated COVID-19 Jab to FDA for Review
Zacks via Yahoo Finance· 6 days agoModerna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19...